Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |